Charles Magness
Direttore/Membro del Consiglio presso Kineta One LLC
Patrimonio netto: 329 439 $ in data 30/06/2024
Posizioni attive di Charles Magness
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Kineta One LLC
 Kineta One LLC Pharmaceuticals: MajorHealth Technology Kineta One LLC provides biotechnology services. The company is headquartered in Seattle, WA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Charles Magness
Precedenti posizioni note di Charles Magness
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Illumigen Biosciences, Inc.
 Illumigen Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Illumigen Biosciences, Inc. provides pharmaceutical research services. It develops human genetic mutations that provide roadmap for therapeutic drug mechanisms. The company's product IB657 helps to investigate the cause of apparent immunity to HCV infection. Illumigen Biosciences was founded by Dr. Charles Magness and Shawn Iadonato in 2000 and is located in Seattle, WA | Direttore operativo | 01/01/2007 | 01/01/2007 |
| Fondatore | 01/01/2007 | 01/01/2007 | |
| Presidente | - | 01/01/2007 | |
| KINETA, INC. | Amministratore Delegato | 01/01/2008 | - |
| Fondatore | 01/01/2008 | - | |
| Presidente | 01/01/2008 | - | |
KPI Therapeutics, Inc.
 KPI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KPI Therapeutics, Inc. operates as a clinical stage biotechnology company, which develops first in class therapies for unmet medical needs in autoimmunity. It offers dalazatide, KPI-150, and KPI-190 for systemic autoimmune diseases including lupus; and CSP conopeptide for chronic pain. The company was founded in 2013 and is headquartered in Seattle, WA. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
| Presidente | - | - | |
| McDonnell Douglas Automation | Corporate Officer/Principal | - | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Amministratore Delegato | 17/09/2009 | - |
| Fondatore | 17/09/2009 | - | |
| Presidente | 17/09/2009 | - |
Formazione di Charles Magness
| Lehigh University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
Posizioni
| President | 4 |
| Chief Executive Officer | 3 |
| Founder | 3 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KINETA, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Kineta One LLC
Kineta One LLC Pharmaceuticals: MajorHealth Technology Kineta One LLC provides biotechnology services. The company is headquartered in Seattle, WA. | Health Technology |
Illumigen Biosciences, Inc.
Illumigen Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Illumigen Biosciences, Inc. provides pharmaceutical research services. It develops human genetic mutations that provide roadmap for therapeutic drug mechanisms. The company's product IB657 helps to investigate the cause of apparent immunity to HCV infection. Illumigen Biosciences was founded by Dr. Charles Magness and Shawn Iadonato in 2000 and is located in Seattle, WA | Health Technology |
| McDonnell Douglas Automation | |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Health Technology |
KPI Therapeutics, Inc.
KPI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KPI Therapeutics, Inc. operates as a clinical stage biotechnology company, which develops first in class therapies for unmet medical needs in autoimmunity. It offers dalazatide, KPI-150, and KPI-190 for systemic autoimmune diseases including lupus; and CSP conopeptide for chronic pain. The company was founded in 2013 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Charles Magness
- Esperienza